What's new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney
- PMID: 40665660
- PMCID: PMC12264474
- DOI: 10.4132/jptm.2025.06.19
What's new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney
Abstract
Diffuse podocytopathy, including minimal change disease and primary focal segmental glomerulosclerosis, is a common cause of nephrotic syndrome in adults and children. It is increasingly recognized to be autoimmune-mediated associated with anti-nephrin and other emerging anti-slit diaphragm antibodies, and can recur in the kidney allograft. Immunofluorescence is routinely used in evaluation of kidney biopsies, and updates include those on fibrillar diseases, monoclonal staining, lupus-like staining, and use of antibody KM55 in IgA-dominant glomerulonephritis.
Figures
References
-
- Hengel FE, Dehde S, Lasse M, Zahner G, Seifert L, Schnarre A, et al. Autoantibodies targeting nephrin in podocytopathies. N Engl J Med. 2024;391:422–33. - PubMed
-
- Shirai Y, Miura K, Ishizuka K, Ando T, Kanda S, Hashimoto J, et al. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int. 2024;105:608–17. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
